HumaScan To Alter BreastAlert Labeling And Ads Following FDA Warning
This article was originally published in The Gray Sheet
Executive Summary
HumaScan is revising the physician labeling for its BreastAlert differential temperature sensor following the receipt of an April 24 FDA warning letter citing labeling and promotional violations related to the device. The company is in the process of changing promotional statements on its website as well.